Literature DB >> 14759390

Outcomes in patients with normal serum creatinine and with artificial renal support for acute renal failure developing after coronary artery bypass grafting.

Marzia Leacche1, James D Rawn, Tomislav Mihaljevic, Julie Lin, Alexandros N Karavas, Subroto Paul, John G Byrne.   

Abstract

This retrospective study of cardiac surgical patients with normal serum creatinine who developed acute renal failure requiring artificial renal support was undertaken to (1) determine the prevalence of acute renal failure and hospital mortality in this subgroup, (2) identify the independent predictors of early mortality, and (3) determine long-term survival and prognosis.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14759390     DOI： 10.1016/j.amjcard.2003.10.020

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  17 in total

1.  Factors associated with postoperative requirement of renal replacement therapy following off-pump coronary bypass surgery.

Authors:  Tomoko S Kato; Yoichiro Machida; Kenji Kuwaki; Taira Yamamoto; Atsushi Amano
Journal:  Heart Vessels       Date:  2016-06-06       Impact factor: 2.037

Review 2.  AKI associated with cardiac surgery.

Authors:  Robert H Thiele; James M Isbell; Mitchell H Rosner
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-06       Impact factor: 8.237

3.  The impact of major perioperative renal insult on long-term renal function and survival after cardiac surgery.

Authors:  Vivek Srivastava; Celma D'Silva; Augustine Tang; Franco Sogliani; Dumbor L Ngaage
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-04-02

4.  Secular trends in acute dialysis after elective major surgery--1995 to 2009.

Authors:  Nausheen F Siddiqui; Steven G Coca; Philip J Devereaux; Arsh K Jain; Lihua Li; Jin Luo; Chirag R Parikh; Michael Paterson; Heather Thiessen Philbrook; Ron Wald; Michael Walsh; Richard Whitlock; Amit X Garg
Journal:  CMAJ       Date:  2012-06-25       Impact factor: 8.262

Review 5.  Paradigms of acute kidney injury in the intensive care setting.

Authors:  John A Kellum; John R Prowle
Journal:  Nat Rev Nephrol       Date:  2018-01-22       Impact factor: 28.314

6.  Preoperative statins improve recovery of renal function but not by an anti-inflammatory effect: observational study in 69 elderly patients undergoing cardiac surgery.

Authors:  Pierangela Presta; Antonino S Rubino; Gaetano Lucisano; Giuseppe F Serraino; Daniela Foti; Elio Gulletta; Attilio Renzulli; Giorgio Fuiano
Journal:  Int Urol Nephrol       Date:  2011-04-20       Impact factor: 2.370

Review 7.  Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment.

Authors:  Ying Wang; Rinaldo Bellomo
Journal:  Nat Rev Nephrol       Date:  2017-09-04       Impact factor: 28.314

8.  Renal dysfunction after off-pump coronary artery bypass surgery- risk factors and preventive strategies.

Authors:  Gaurab Maitra; Ahsan Ahmed; Amitava Rudra; Ravi Wankhede; Saikat Sengupta; Tanmoy Das
Journal:  Indian J Anaesth       Date:  2009-08

9.  Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy.

Authors:  Vin-Cent Wu; Wen-Je Ko; Hong-Wei Chang; Yung-Wei Chen; Yu-Feng Lin; Chih-Chung Shiao; Yung-Ming Chen; Yih-Sharng Chen; Pi-Ru Tsai; Fu-Chang Hu; Jann-Yuan Wang; Yen-Hung Lin; Kwan-Dun Wu
Journal:  Intensive Care Med       Date:  2007-08-15       Impact factor: 17.440

10.  Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative.

Authors:  Claudio Ronco; Peter McCullough; Stefan D Anker; Inder Anand; Nadia Aspromonte; Sean M Bagshaw; Rinaldo Bellomo; Tomas Berl; Ilona Bobek; Dinna N Cruz; Luciano Daliento; Andrew Davenport; Mikko Haapio; Hans Hillege; Andrew A House; Nevin Katz; Alan Maisel; Sunil Mankad; Pierluigi Zanco; Alexandre Mebazaa; Alberto Palazzuoli; Federico Ronco; Andrew Shaw; Geoff Sheinfeld; Sachin Soni; Giorgio Vescovo; Nereo Zamperetti; Piotr Ponikowski
Journal:  Eur Heart J       Date:  2009-12-25       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.